As of April 16, 2025, MoonLake Immunotherapeutics (MLTX) has a market cap of $2.33 billion USD. According to our data, MoonLake Immunotherapeutics is ranked No.3759 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.33 B |
-31.86%
|
Dec 31, 2024 | $3.41 B |
-10.33%
|
Dec 29, 2023 | $3.81 B |
475.14%
|
Dec 30, 2022 | $0.66 B |
6.17%
|
Dec 31, 2021 | $0.62 B |
-13.02%
|
Dec 31, 2020 | $0.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
Market Cap | = | MLTX Stock Price | * | MLTX Shares Outstanding |
= | $36.77 | * | 63.28 M | |
= | $2.33 B |